


The Invesco Perpetual European High Income Fund aims to achieve a high level of income and capital growth through a portfolio of primarily European equity and fixed interest securities.
| Name | % Net Assets | 
|---|---|
| Roche | 4.3% | 
| SLM SEK FRN 15/6/2010 | 2.9% | 
| Koninklijke KPN | 2.6% | 
| Novartis | 2.2% | 
| Vivendi Universal | 1.8% | 
| Telekom Austria | 1.8% | 
| Rexam 6.75% € Bonds 29/6/2017 | 1.8% | 
| GDF Suez | 1.8% | 
| Banque Cantonale Vaudoise | 1.8% | 
| John Lewis 8.375% £ Bonds 8/4/2019 | 1.7% | 
| Key | % Net Assets | 
|---|---|
| 4.3% | |
| 2.9% | |
| 2.6% | |
| 2.2% | |
| 88% | 
| Date | 19-Aug-2022 | 
|---|---|
| NAV | 234.41p | 
| Currency | GBP | 
| Change | 0.000p | 
| % | n/a | 
| YTD change | 234.41p | 
| YTD % | n/a | 
| Fund Inception | 01/05/2008 | 
|---|---|
| Fund Manager | n/a | 
| TER | 1.01 (31-Dec-2013) | 
| Minimum Investment | |
|---|---|
| Initial | n/a | 
| Additional | n/a | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | n/a | 
| Annual Mang't | 1.02% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| No risk data available. | |
You are here: research